ID
12318
Description
Randomized study with a run-in dose-selection phase to assess the added value of Lenalidomide in combination with standard remission-induction chemotherapy and post-remission treatment in patients aged 18-65 years with previously untreated acute myeloid leukemia (AML) or high risk myelodysplasia (MDS) (IPSS-R risk score> 4.5) Form Description: Lenalidomide Maintenance and Observation Evaluation Form
Keywords
Versions (3)
- 11/9/15 11/9/15 -
- 12/28/15 12/28/15 -
- 2/11/16 2/11/16 -
Uploaded on
November 9, 2015
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Lenalidomide Maintenance and Observation Evaluation Form HOVON 132 AML/SAKK 30/13 EudraCT 2013-002843-26
Lenalidomide Maintenance and Observation Evaluation Form
- StudyEvent: ODM
Description
Remission Status
Alias
- UMLS CUI-1
- C0544452
- UMLS CUI-2
- C0449438
Description
Assessment Date
Data type
date
Measurement units
- dd/mm/yyyy
Alias
- UMLS CUI [1]
- C2985720
Description
Remission status
Data type
integer
Alias
- UMLS CUI [1,1]
- C0544452
- UMLS CUI [1,2]
- C0449438
- UMLS CUI [1,3]
- C0686584
Description
undefined item
Data type
text
Description
Date of Relapse
Data type
date
Measurement units
- dd/mm/yyyy
Alias
- UMLS CUI [1,1]
- C0035020
- UMLS CUI [1,2]
- C0011008
Description
Survival status
Data type
integer
Alias
- UMLS CUI [1]
- C1148433
Description
Comments
Similar models
Lenalidomide Maintenance and Observation Evaluation Form
- StudyEvent: ODM
C0449438 (UMLS CUI [1,2])
C0686584 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,2])